Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
Jong Hwa Jun,1 Wern-Joo Sohn,2 Youngkyun Lee,2 Jae-Young Kim21Department of Ophthalmology, School of Medicine, Dongsan Medical Center, Keimyung University, 2Department of Oral Biochemistry, School of Dentistry, IHBR, Kyungpook National University, Daegu, South KoreaAbstract: The molecular a...
Main Authors: | Jun JH, Sohn WJ, Lee Y, Kim JY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/effects-of-anti-vascular-endothelial-growth-factor-monoclonal-antibody-peer-reviewed-article-OPTH |
Similar Items
-
Vascular endothelial growth factor blocking agents in retinal vein occlusion
by: Chris Canning
Published: (2008-01-01) -
A study on the contamination of injection bevacizumab on storage of multidose vials
by: Ketan Saoji, et al.
Published: (2018-01-01) -
Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan
by: Amna Rizwan, et al.
Published: (2022-01-01) -
Induction of vascular endothelial growth factor receptor expression in human umbilical vein endothelial cells after repeated bevacizumab treatment in vitro
by: Ji Eun Lee, et al.
Published: (2017-07-01) -
Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab
by: Muñoz-Villegas P, et al.
Published: (2021-05-01)